Skip to main content
 This program is not active.
On Demand

Immunotherapy in Lung Cancer


Total Credits: 1 including 1 AOA Category 1-A Credit(s)

Average Rating:
Not yet rated
State Associations:
TOMA - Texas
Faculty:
Theodore Pollock
Duration:
45 Minutes
Expiration:
Never expires.


Description

Immunotherapy in Lung Cancer
Theodore Pollock, DO
This presentation will provide an update on advancements in immunotherapy options for lung cancer patients.

Objectives:
  1. Identify advancements in immunotherapy 
  2. Educate on new clinical trials to develop more options for cancer care

Statement of Accreditation
The Texas Osteopathic Medical Association (TOMA) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. TOMA designates is program for a maximum of 1 AOA Category 1-A credits and will report CME credits commensurate with the extent of the physician’s participation in this activity.

Grievance Policy
All grievances may be directed to TOMA's Executive Director at toma@txosteo.org. All grievances will receive an initial response within 30 days of receipt.  If the participant does not receive a satisfactory response, they can submit a complaint to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.

 

Handouts

Faculty

Theodore Pollock Related Seminars and Products


Director of Medical Oncology at Cancer Treatment Centers of America® (CTCA) in Tulsa, Dr. Theodore Pollock brings over 30 years of oncology experience to people fighting cancer at CTCA®. He treats a number of malignancies, with a particular focus on lung cancer.

Dr. Pollock is board certified and a Fellow of the American College of Osteopathic Internists (FACOI). Before attending medical school, he earned a bachelor’s degree in biology from Guilford College in Greensboro, North Carolina. In 1973, Dr. Pollock earned an osteopathic medical degree from Kirksville College of Osteopathic Medicine in Kirksville, Missouri. He then completed an internship and residency at Doctors Hospital in Columbus, Ohio, as well as a medical oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York. While there, Dr. Pollock was also a clinical instructor of medicine at Cornell Medical College.

Dr. Pollock joined the Medical Oncology Department at CTCA in 2008.

Dr. Pollock discloses that he has no relevant financial relationships with any organization producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.


Reviews